The DOI matches its Crossref record; 45 of the 48 references it cites were found in a registry or an index.
A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity
Open accessAbstract
p53 has a key role in the negative regulation of cell proliferation, in the maintenance of genomic stability, and in the suppression of transformation and tumorigenesis. To identify novel regulators of p53, we undertook two functional screens to isolate genes which bypassed either p53-mediated growth arrest or apoptosis. In both screens, we isolated cDNAs encoding macrophage migration inhibitory factor (MIF), a cytokine that was shown previously to exert both local and systemic proinflammatory activities. Treatment with MIF overcame p53 activity in three different biological assays, and suppressed its activity as a transcriptional activator. The observation that a proinflammatory cytokine, MIF, is capable of functionally inactivating a tumor suppressor, p53, may provide a link between inflammation and tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MIF is a potent cytokine that overcomes p53 function by suppressing its transcriptional activity33.”
From Inflammation and cancer (2002) · cites this paper as [33]
In the citing paper
“tetracycline regulated expression of wild-type p53 (GFP tagged) in the TGP53-4 mouse cell line (27) caused a significant decline in endogenous PGM activity (Fig. 5B).”
From Glycolytic Enzymes Can Modulate Cellular Life Span (2005) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J. D., Xie, Q. W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,245
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Self-citationp53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Transcriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · cited 1×
“the tetracycline inducible system (22), and pBabe-puro-tet-GFP-”
Flagged first, then by citations
3 of the 48 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Christen, 1999, Chronic infection and inflammation lead to cancer
Cited by
Sorted by citations
Items 101–200 of 649
Funamizu, N., Hu, C., Lacy, C., Schetter, A. J., Zhang, G., He, P., Gaedcke, J., Ghadimi, M. B., Ghadimi, Β. M., Yfantis, H. G., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27736 · Cited by 134
Hoi, A. Y.-B., Hickey, M. J., Hall, P., Yamana, J., O’Sullivan, K. M., Santos, L. L., James, W. G., Kitching, A. R., & Morand, E. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5687 · Cited by 133
Burger‐Kentischer, A., Göbel, H., Kleemann, R., Zernecke, A., Bucala, R., Leng, L., Finkelmeier, D., Geiger, G., Schaefer, H. E., Schober, A., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.028 · Cited by 131
The Absence of LPA2 Attenuates Tumor Formation in an Experimental Model of Colitis-Associated Cancer
Lin, S., Wang, D., Iyer, S. S., Ghaleb, A. M., Shim, H., Yang, V. W., Chun, J. J. M., & Yun, C. C. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.002 · Cited by 130
Macrophage Migration Inhibitory Factor Activates Hypoxia-Inducible Factor in a p53-Dependent Manner
Oda, S., Oda, T., Nishi, K., Takabuchi, S., Wakamatsu, T., Tanaka, T., Adachi, T., Fukuda, K., Semenza, G. L., & Hirota, K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002215 · Cited by 129
Macrophages in the embryo and beyond: Much more than just giant phagocytes
Ovchinnikov, D. A. (2008) · genesis · doi:10.1002/dvg.20417 · Cited by 127
PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors
Zwerner, J. P., & May, W. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204133 · Cited by 128
Satoskar, A. R., Bozza, M. T., Rodríguez‐Sosa, M., Lin, G., & David, J. R. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.906-911.2001 · Cited by 127
New mechanisms and therapeutic potential of curcumin for colorectal cancer
Villegas, I., Sánchez‐Fidalgo, S., & Alarcón‐de‐la‐Lastra, C. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700280 · Cited by 126
MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential
Penticuff, J. C., Woolbright, B. L., Sielecki, T. M., Weir, S. J., & Taylor, J. A. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0171-9 · Cited by 125
Dios, A., Mitchell, R. A., Aljabari, B., Lubetsky, J. B., O'Connor, K., Liao, H., Senter, P. D., Manogue, K. R., Lolis, E., Metz, C. N., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010534q · Cited by 124
Baumann, R., Casaulta, C., Simon, D., Conus, S., Yousefi, S., & Simon, H. (2003) · The FASEB Journal · doi:10.1096/fj.03-0110com · Cited by 123
Liu, D., Chang, C., Lü, N., Wang, X., Lu, Q., Ren, X., Ren, P., Zhao, D., Wang, L., Zhu, Y., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00604 · Cited by 122
p53 and the Carcinogenicity of Chronic InflammationPreprint
Gudkov, A. V., & Komarova, E. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026161 · Cited by 126
The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors
Jia, X., Geng, L., Jiang, P., Xu, H., Nan, K., Yao, Y., Jiang, L., Sun, H., Qin, T., & Guo, H. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01749-x · Cited by 120
Macrophage Migration Inhibitory Factor Promotes Colorectal Cancer
He, X., Chen, K., Yang, J., Li, X., Gan, H., Liu, C., Coleman, T. R., & Al‐Abed, Y. (2009) · Molecular Medicine · doi:10.2119/molmed.2008.00107 · Cited by 119
Untargeted effects of ionizing radiation: Implications for radiation pathology
Wright, E. G., & Coates, P. J. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.03.035 · Cited by 119
Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk
Sarode, P., Schaefer, M. B., Grimminger, F., Seeger, W., & Savai, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00324 · Cited by 116
Sharma, B., Nawandar, D. M., Nannuru, K. C., Varney, M. L., & Singh, R. K. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0529 · Cited by 116
Regulation of the CTL Response by Macrophage Migration Inhibitory Factor
Abe, R., Peng, T., Sailors, J., Bucala, R., & Metz, C. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.747 · Cited by 116
New tools for functional mammalian cancer genetics
Brummelkamp, T. R., & Bernards, R. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1191 · Cited by 114
Pathologies Associated with the p53 ResponsePreprint
Gudkov, A. V., & Komarova, E. A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001180 · Cited by 119
Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis
Leech, M. T., Lacey, D. C., Xue, J. R., Santos, L. L., Hutchinson, P. E., Wolvetang, E. J., David, J. R., Bucala, R., & Morand, E. F. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11165 · Cited by 114
Control of p53 and NF-κB signaling by WIP1 and MIF: Role in cellular senescence and organismal aging
Salminen, A., & Kaarniranta, K. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2010.10.012 · Cited by 111
Winner, M. G., Koong, A. C., Rendon, B. E., Zundel, W., & Mitchell, R. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3292 · Cited by 111
Control of fibroblast‐like synoviocyte proliferation by macrophage migration inhibitory factor
Lacey, D. C., Sampey, A. V., Mitchell, R. A., Bucala, R., Santos, L., Leech, M. T., & Morand, E. F. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10733 · Cited by 111
Giannini, S. L., Hubert, P., Doyen, J., Boniver, J., & Delvenne, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.10084 · Cited by 111
The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development
Wigner, P., Grębowski, R., Bijak, M., Saluk, J., & Szemraj, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094483 · Cited by 113
Production of complex nucleic acid libraries using highly parallel in situ oligonucleotide synthesis
Cleary, M. A., Kilian, K. A., Wang, Y., Bradshaw, J., Cavet, G., Ge, W., Kulkarni, A., Paddison, P. J., Chang, K., Sheth, N. U., et al. (2004) · Nature Methods · doi:10.1038/nmeth724 · Cited by 108
Self-citationMeyer‐Siegler, K. L., Leifheit, E. C., & Vera, P. L. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-34 · Cited by 108
Jung, H., Seong, H., & Ha, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800050200 · Cited by 106
Klemke, L., Oliveira, T. D., Witt, D., Winkler, N., Bohnenberger, H., Bucala, R., Conradi, L., & Schulz‐Heddergott, R. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03426-z · Cited by 106
Bando, H., Matsumoto, G., Bando, M., Muta, M., Ogawa, T., Funata, N., Nishihira, J., Koike, M., & Toi, M. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01269.x · Cited by 106
Reinart, N., Nguyen, P., Bouças, J., Rosen, N., Kvasnicka, H. M., Heukamp, L. C., Rudolph, C., Ristovska, V., Velmans, T., Mueller, C., et al. (2012) · Blood · doi:10.1182/blood-2012-05-431452 · Cited by 107
Hira, E., Ono, T., Dhar, D. K., El-Assal, O. N., Hishikawa, Y., Yamanoi, A., & Nagasue, N. (2004) · Cancer · doi:10.1002/cncr.20818 · Cited by 106
富安, 真., Yoshino, I., Suemitsu, R., Okamoto, T., & Sugimachi, K. (2002) · PubMed · Cited by 105
Link Between Macrophage Migration Inhibitory Factor and Cellular Redox Regulation
Thiele, M., & Bernhagen, J. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1234 · Cited by 114
Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study
Scott, M. E., Shvetsov, Y. B., Thompson, P. J., Hernandez, B. Y., Zhu, X., Wilkens, L. R., Killeen, J. L., Vo, D. D., Moscicki, A., & Goodman, M. T. (2013) · International Journal of Cancer · doi:10.1002/ijc.28119 · Cited by 101
Macrophage Migration Inhibitory Factor
Hardman, M. J., Waite, A., Zeef, L. A. H., Burow, M. E., Nakayama, T., & Ashcroft, G. S. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61241-2 · Cited by 101
Hypoxia and Senescence: The Impact of Oxygenation on Tumor Suppression
Welford, S. M., & Giaccia, A. J. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0065 · Cited by 103
Bacher, M., Schrader, J., Thompson, N. A., Kuschela, K., Gemsa, D., Waeber, G., & Schlegel, J. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63793-5 · Cited by 99
A Leishmania Ortholog of Macrophage Migration Inhibitory Factor Modulates Host Macrophage Responses
Kamir, D., Zierow, S., Leng, L., Cho, Y., Díaz, Y. R., Griffith, J. W., McDonald, C., Merk, M., Mitchell, R. A., Trent, J. O., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8250 · Cited by 99
Chen, Y.-F., Wang, Y., Huang, W.-S., Lee, M.-M., Wood, W. G., Leung, Y., & Tsai, H.-Y. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8395-9 · Cited by 99
Bloom, J., Sun, S., & Al‐Abed, Y. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1251582 · Cited by 98
Inácio, A. R. L., Ruscher, K., Leng, L., Bucala, R., & Deierborg, T. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.194 · Cited by 97
Macrophage Migration Inhibitory Factor (MIF): A Key Player in Protozoan Infections
Ruiz‐Rosado, J. D. D., & Rodríguez‐Sosa, M. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1239 · Cited by 96
The Role of Macrophage Migration Inhibitory Factor in Alzheimer’s Disease
Bacher, M., Deuster, O., Aljabari, B., Egensperger, R., Neff, F., Jessen, F., Popp, J., Noelker, C., Reese, J. P., Al‐Abed, Y., et al. (2010) · Molecular Medicine · doi:10.2119/molmed.2009.00123 · Cited by 92
Macrophage migration inhibitory factor
Lolis, E., & Bucala, R. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.2.153 · Cited by 95
Meyer‐Siegler, K. L., Vera, P. L., Iczkowski, K. A., Bifulco, C. B., Lee, A., Gregersen, P. K., Leng, L., & Bucala, R. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364427 · Cited by 95
Inflammation as a Target for Prostate Cancer Chemoprevention: Pathological and Laboratory Rationale
Lucia, M. S., & Torkko, K. C. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000108142.53241.47 · Cited by 95
Arndt, U., Wennemuth, G., Barth, P. J., Nain, M., Al‐Abed, Y., Meinhardt, A., Gemsa, D., & Bacher, M. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9298-9306.2002 · Cited by 95
Exercise delays allogeneic tumor growth and reduces intratumoral inflammation and vascularization
Zielinski, M. R., Muenchow, M., Wallig, M. A., Horn, P. L., & Woods, J. A. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01210.2003 · Cited by 94
Ren, Y., Chan, H. M., Li, Z., Lin, C.-L. S., Nicholls, J. M., Chen, C. F., Lee, P. Y., Lui, V. C. H., Bacher, M., & Tam, P. K. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207490 · Cited by 94
Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways
Eismann, E. A., Cash, E. D., & Sephton, S. E. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.12.011 · Cited by 96
Current developments of macrophage migration inhibitory factor (MIF) inhibitors
Xu, L., Li, Y., Sun, H., Zhen, X., Qiao, C., Tian, S., & Hou, T. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.12.013 · Cited by 92
Mittelbronn, M. G. A., Platten, M., Zeiner, P. S., Dombrowski, Y., Frank, B., Zachskorn, C., Harter, P. N., Weller, M., & Wischhusen, J. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0858-3 · Cited by 93
Conboy, L., Varea, E., Castro, J. E., Ouertatani-Sakouhi, H., Calandra, T., Lashuel, H. A., & Sandi, C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.15 · Cited by 93
McClelland, M., Zhao, L., Carskadon, S. L., & Arenberg, D. A. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080463 · Cited by 90
Erdélyi, I., Levenkova, N., Lin, E. Y., Pinto, J. T., Lipkin, M., Quimby, F. W., & Holt, P. R. (2009) · Journal of Nutrition · doi:10.3945/jn.108.104125 · Cited by 90
Hypoxia and HIF-1 activation in bacterial infections
Devraj, G., Beerlage, C., Brüne, B., & Kempf, V. A. J. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.11.003 · Cited by 95
Macrophage Migration Inhibitory Factor MIF Interferes with the Rb-E2F Pathway
Petrenko, O., & Moll, U. M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.052 · Cited by 89
Role of macrophage migration inhibitory factor (MIF) in the skin
Shimizu, T. (2004) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2004.08.007 · Cited by 88
Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions
Rajasekaran, D., Gröning, S., Schmitz, C., Zierow, S., Drucker, N., Bakou, M., Kohl, K., Mertens, A., Lue, H., Weber, C., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.717751 · Cited by 90
Tumour escape: antitumour effectors too much of a good thing?
Pawelec, G. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0469-5 · Cited by 85
Inflammation and the chemical carcinogen benzo[a]pyrene: Partners in crime
Shi, Q., Godschalk, R., & van Schooten, F. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.08.003 · Cited by 88
Inflammatory Doses of UV May Not Be Necessary for Skin Carcinogenesis†
Halliday, G. M., & Lyons, J. G. (2007) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00247.x · Cited by 85
The Multitasking Potential of Alarmins and Atypical Chemokines
Kapurniotu, A., Gökçe, Ö., & Bernhagen, J. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00003 · Cited by 85
Nguyen, M. T., Beck, J., Lue, H., Fünfzig, H., Kleemann, R., Koolwijk, P., Kapurniotu, A., & Bernhagen, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301735200 · Cited by 84
Aging and Inflammation: Etiological Culprits of Cancer
Ahmad, A., Banerjee, S., Wang, Z. P., Kong, D., Majumdar, A. P. N., & Sarkar, F. H. (2009) · Current Aging Science · doi:10.2174/1874609810902030174 · Cited by 83
Maaser, C., Eckmann, L., Paesold, G., Kim, H. S., & Kagnoff, M. F. (2002) · Gastroenterology · doi:10.1053/gast.2002.31891 · Cited by 83
Huang, H., Zhu, J., Li, Y., Zhang, L., Gu, J., Xie, Q., Jin, H., Che, X., Li, J., Huang, C., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1196313 · Cited by 82
Chemokine-like functions of MIF in atherosclerosis
Schober, A., Bernhagen, J., & Weber, C. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0334-2 · Cited by 82
Identifying and defusing weapons of mass inflammation in carcinogenesis
Hofseth, L. J., & Ying, L. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.08.005 · Cited by 81
Ren, Y., Law, S. Y.-K., Huang, X., Lee, P. Y., Bacher, M., Srivastava, G., & Wong, J. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000168555.97710.bb · Cited by 81
Dalgleish, A. G., & O'Byrne, K. J. (2006) · Cancer treatment and research · doi:10.1007/0-387-26283-0_1 · Cited by 81
Nickoloff, B. J. (2001) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2001.280201.x · Cited by 78
The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors
Bach, J., Deuster, O., Balzer‐Geldsetzer, M., Meyer, B., Dodel, R. C., & Bacher, M. (2009) · Cancer · doi:10.1002/cncr.24245 · Cited by 80
Macrophage Migration Inhibitory Factor and Host Innate Immune Responses to Microbes
Calandra, T. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310016277 · Cited by 80
Macrophage Migration Inhibitory Factor and Host Innate Immune Defenses against Bacterial Sepsis
Calandra, T., Froidevaux, C., Martin, C., & Roger, T. (2003) · The Journal of Infectious Diseases · doi:10.1086/374752 · Cited by 80
Leyton-Jaimes, M. F., Kahn, J., & Israelson, A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.06.021 · Cited by 80
The Role of Inflammation in Cervical Cancer
Sankaran, D., Marzook, K. H., & Pillai, M. R. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-0348-0837-8_15 · Cited by 79
Autoimmune diseases: MIF as a therapeutic target
Greven, D., Leng, L., & Bucala, R. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903551304 · Cited by 79
Cross, J. V., Rady, J. M., Foss, F. W., Lyons, C. E., Macdonald, T. L., & Templeton, D. J. (2009) · Biochemical Journal · doi:10.1042/bj20091170 · Cited by 78
Macrophage migration inhibitory factor: a neuroendocrine modulator of chronic inflammation
Baugh, J. A., & Donnelly, S. C. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1790015 · Cited by 78
MIF Maintains the Tumorigenic Capacity of Brain Tumor–Initiating Cells by Directly Inhibiting p53
Fukaya, R., Ohta, S., Yaguchi, T., Matsuzaki, Y., Sugihara, E., Okano, H., Saya, H., Kawakami, Y., Kawase, T., Yoshida, K., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1011 · Cited by 80
Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer’s disease
Zhang, S., Zhao, J., Zhang, Y., Zhang, Y., Cai, F., Wang, L., & Song, W. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0508-x · Cited by 73
Parthanatos in the pathogenesis of nervous system diseases
Wang, X., & Ge, P. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.09.049 · Cited by 75
Bucala, R. (2000) · Nature · doi:10.1038/35041654 · Cited by 77
p53 protects against LPS-induced lung endothelial barrier dysfunction
Barabutis, N., Dimitropoulou, C., Birmpas, C., Joshi, A., Thangjam, G. S., & Catravas, J. D. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00334.2014 · Cited by 76
Macrophage Migration Inhibitory Factor Mediates Hypoxia-Induced Pulmonary Hypertension
Zhang, Y., Talwar, A., Tsang, D., Bruchfeld, A. N., Sadoughi, A., Hu, M., OMONUWA, K. O., Cheng, K. F., Al‐Abed, Y., & Miller, E. J. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00094 · Cited by 74
Human herpesvirus-8 and Kaposi's sarcoma: Relationship with the multistep concept of tumorigenesis
Stürzl, M., Zietz, C., Monini, P., & Ensoli, B. (2001) · Advances in cancer research · doi:10.1016/s0065-230x(01)81004-6 · Cited by 76
Macrophage migration inhibitory factor: A key cytokine and therapeutic target in colon cancer
Gordon-Weeks, A. N., Lim, S. Y., Yuzhalin, A. E., Jones, K. I., & Muschel, R. J. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.03.002 · Cited by 75
Cell and tissue responses to genotoxic stress
Coates, P. J., Lorimore, S. A., & Wright, E. G. (2005) · The Journal of Pathology · doi:10.1002/path.1701 · Cited by 77
Leng, L., & Bucala, R. (2006) · Cell Research · doi:10.1038/sj.cr.7310022 · Cited by 74
Macrophage migration inhibitory factor of the parasitic nematode Trichinella spiralis
TAN, T. H. P., EDGERTON, S. A. V., KUMARI, R., McALISTER, M. S. B., ROWE, S. M., NAGL, S., PEARL, L. H., SELKIRK, M. E., BIANCO, A. E., TOTTY, N. F., et al. (2001) · Biochemical Journal · doi:10.1042/bj3570373 · Cited by 50
A Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF)
Bai, F., Asojo, O. A., Cirillo, P. F., Ciustea, M., Ledizet, M., Aristoff, P. A., Leng, L., Koski, R. A., Powell, T., Bucala, R., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.385583 · Cited by 74
Roger, T., Delaloye, J., Chanson, A.-L., Giddey, M., Roy, D. L., & Calandra, T. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis673 · Cited by 75
Roger, T., Schneider, A., Weier, M., Sweep, F. C. G. J., Roy, D. L., Bernhagen, J., Calandra, T., & Giannoni, É. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514018113 · Cited by 73
Petrenko, O., Fingerle‐Rowson, G., Peng, T., Mitchell, R. A., & Metz, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211985200 · Cited by 72
Metadata
- Authors
- Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., & Beach, D. H.
- Affiliations
- aUnit of Cancer Biology, Institute of Child Health, London WC1N 1EH, United Kingdom
- Centro di Riferimento Oncologico (IT)
- Cold Spring Harbor Laboratory (US)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-11-15
- Volume
- 190
- Issue
- 10
- Pages
- 1375-1382
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2195698
- OpenAlex
- W2110929110
- Cited by
- 649
- References
- 48
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 14 · 2023: 10 · 2022: 12 · 2021: 18 · 2020: 25 · 2019: 17 · 2018: 14 · 2017: 14 · 2016: 27 · 2015: 24 · 2014: 25 · 2013: 25 · 2012: 38
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, other-oa)
- Funders
- University College London
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- p53, macrophage migration inhibitory factor, inflammatory cytokines, tumor suppressor inactivation, inflammation and tumorigenesis, p53 transcriptional activation, apoptosis, cell proliferation, genome stability
- MeSH terms
- Animals, Cell Line, Chronic Disease, Fibroblasts, Inflammation, Macrophage Migration-Inhibitory Factors, Neoplasms, Nitric Oxide, Transcriptional Activation, Tumor Suppressor Protein p53, Apoptosis, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review